The NMPA publicly solicited opinions on the Announcement of Matters concerning the Transfer of Products with The Registration Certificate of Imported Medical Devices to Enterprises within the territory of China (Draft for Comments)
In order to implement the "regulation and service" reform and optimize the business environment, we will deepen the reform of the medical device evaluation and approval system, further simplify and optimize the requirements for medical device licensing, and meet the people's needs for use. The NMPA has organized the drafting of the Announcement on Matters Concerning the imported certificated medical devices products transfer to Chinese domestic enterprise production related matters (Draft for Comments), it is now open for public comments. Please send your comments or Suggestions by email to ylqxzc@sina.cn before March 31, 2020. Please indicate "feedback on matters related to product transfer and production" in the email subject.